Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

Clinical trial NCT01161563 · COMPLETED

Trial details

NCT number: NCT01161563
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2010-07-01
Primary completion: 2011-04-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.